Kimberley T Lee, Melanie Buhlmann, Clement K Gwede, L. Robert Gore, I-Wen Pan, Yi Luo, Shelley S Tworoger, Susan Thomas Vadaparampil, and Heather S.L. Jim. Impact of endocrine therapy adherence on racial disparities in breast cancer survival. Journal of Clinical Oncology 2023 41:16_suppl, 541-541. , American Society of Clinical Oncology Annual Meeting, Chicago, Il.: 2023
Ricardo L Costa, Jennifer A Childress, Edith Abraham, Carly Farrell, Qianxing Mo, Zena Jameel, Aixa Elena Soyano Muller, Kimberley T Lee, Susan Hoover, John Kiluk, Robert J Weinfurtner, Marie Catherine Lee, Christine Laronga, Nazanin Khakpour, Hyo S. Han, Hung T. Khong, Hatem Hussein Soliman, Brian J. Czerniecki. Phase 1 dose-escalation, dose-expansion trial of intratumoral HER2- and HER3-primed dendritic cells injections for the treatment of early-stage TNBC and HR low positive breast cancer: DecipHER trial. , American Society of Clinical Oncology Annual Meeting, Chicago, IL.: 2023
Hyo S. Han, Ricardo L Costa, Hatem Hussein Soliman, Aixa Soyano, Hung T. Khong, Loretta S. Loftus, Kimberley T Lee, Avan J. Armaghani, Hien Liu, Jessica Malka, Frederick L. Locke, Qianxing Mo, Junmin Whiting, Lavakumar Karyampudi, Elizabeth E. Evans, Terrence Lee Fisher, Maurice Zauderer, Brian J. Czerniecki Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC). , American Society of Clinical Oncology Annual Meeting, Chicago, IL.: 2023
Sheffield KM, Peachey JR, Method M, Grimes BR, Brown J, Saverno K, Sugihara T, Lin Cui Z, Lee KT. A Real World US Study of Recurrence Risks using Combined Clinicopathologic Features in HR+, HER2- Early Breast Cancer. , Future Oncol
, 18(21): 2022,2667-2682.
Lee, KT. “Racial Disparities in Breast Cancer.” , American Society of Clinical Oncology Annual Meeting, Chicago, IL.: 2022
Islam JY, Hathaway C, Lee KT, Hume E, Turner K, Hallanger-Johnson JE, Tworoger S, Camacho-Rivera M. Racial/ethnic disparities of cancer treatment disruptions among patients with breast cancer with SARS-CoV-2 infection: An analysis of the ASCO Survey on COVID-19 in Oncology Registry. , American Society of Clinical Oncology Annual Meeting, Chicago, IL,: 2022
Haval N, Lee KT, Alcorn D, Mangini N, Stearns V. Incidence and severity of myelosuppression with palbociclib after palliative bone radiation in advanced breast cancer: A single center experience and review of literature. , Clin Breast Cancer, 22(1): 2022,e65-e73.
Unknown Speaker, Moffitt Cancer Center Breast Cancer Awareness Month Webinar Series. “Breast Cancer 101.” , Unknown: 2022
Fulton HJ, Charles DR, Geiss C, Gonzalez B, Jim H, Gwede C, Tworoger S, Lee KT. Barriers to use of adjuvant endocrine therapy among Black women with breast cancer: A qualitative investigation. , American Association of Cancer Research Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Undeserved, Philadelphia PA.: 2022
Unknown Speaker, Moffitt Breast dinner community program. “Closing the gap in breast cancer disparities.” , Unknown: 2022
